Lilly registers three new early trials: olomorasib in colorectal cancer, two obesity studiesSep 11Weekly roundup, 3 itemsEli Lillyeloralintide
Vertex registers Phase 1 drug interaction study for VX-407 with oral contraceptivesAug 28Trial updateVertex Pharmaceuticals Inc / Ma
Dare Bioscience reports Q2 2026 results as first direct product launchesAug 13Quarterly updateDare Bioscience, Inc.
Viatris raises 2026 guidance, reports FDA approvals and Tyrvaya sale in Q2 updateAug 6Quarterly updatevareniclineViatris Inc.
Sign inSign in